2019's second unicorn Gossamer raises $276M in upsized IPO offering, MPM's Harpoon makes its Nasdaq debut with $75.6M bounty
Meet 2019’s newest biotech unicorn — Gossamer Bio — which is making its debut on Nasdaq Friday with an upsized $276 million offering.
The drug developer …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.